Name: REGN Income Statement - Regeneron Pharmaceuticals Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

REGN - Regeneron Pharmaceuticals, Inc.

USD | NASDAQ | Healthcare

REGN Income Statement - Regeneron Pharmaceuticals Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	3,605.4	3,884.3	3,754.3	3,675.6	3,028.7	3,789.2	3,720.7	3,547.1	3,145.0	3,434.3	3,362.7	3,158.1	3,162.1	3,414.4	2,936.2	2,857.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	14,919.6	14,342.9	14,202.0	13,117.2	12,172.9	16,071.7	8,497.1	6,557.6	5,145.6	5,872.2	4,860.4	4,103.7	2,819.6	2,104.7	1,378.5	445.8	459.1	379.3
Cost of Revenue	-	-	-	-	-	-	-	402.8	237.5	202.5	194.6	241.7	129.0	118.0	83.9	4.2	2.1	1.7
Gross Profit	-	-	-	-	-	-	-	6,154.8	4,908.1	5,669.7	4,665.8	3,862.0	2,690.5	1,986.7	1,294.6	441.6	457.0
Operating Expenses
Research & Development	6,066.3	5,850.2	5,132.0	4,439.0	3,592.5	2,860.1	2,647.0	2,450.0	1,468.8	2,075.1	2,052.3	1,620.6	1,271.4	859.9
Operating Income
Operating Income	3,629.1	3,577.9	3,990.7	4,047.1	4,738.9	8,946.8	3,576.6	2,209.8	2,534.4	2,079.6	1,330.7	1,251.9	823.9	743.1
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax & Net
Income Tax Expense	733.5	725.8	367.3	245.7	520.4	1,250.5	297.2	313.3	109.1	880.0	434.3	589.0	423.1	282.6	(335.8)
Per Share
EPS Basic	42.53	43.07	40.90	37.05	40.51	76.40	32.65	19.38	22.65	11.27	8.55	6.17	3.36	4.23	7.92	(2.45)
Supplementary Data
EBITDA	-	4,121.6	4,473.6	4,468.1	5,080.3	9,233.0	3,812.5	2,420.1	2,682.6	2,225.1	1,435.4	1,326.8	876.6	784.3	494.7	(174.1)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	1,543.5	1,626.1	1,475.0	1,421.7	1,327.4	1,412.1	1,271.5	1,200.0	1,248.4	1,177.2	1,075.3	1,085.3	1,101.2	1,043.1	911.3	794.3	843.8	737.6	665.4	714.2	742.9	656.5	684.6	722.0	583.9	552.4	526.0	885.5	486.1	(116.1)	557.0	529.3	498.6	527.9	529.7	510.0	507.4	479.2	543.0	559.9
Selling General & Administrative	647.7	775.0	657.8	634.2	633.0	792.2	714.4	758.8	689.0	737.7	640.5	652.0	601.1	660.5	529.1	476.3
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	123.2	-	-	-	126.9	-	-	-	114.1	-	-	-	99.5	-	-	-
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15.6	-	-
Other Operating Expenses	-	0.0	10.0	0.0	0.0	(15.5)	(8.0)	(14.6)	(15.3)	0.5	0.5	0.6	0.5	6.6	45.7	17.4	20.2
Total Operating Expenses	2,962.5	3,004.4	2,727.5	2,596.1	2,437.0	2,799.0	2,541.2	2,477.5	2,393.6	2,461.4	2,251.7	2,141.6	2,215.4	2,267.6	1,712.5

Operating Income
Operating Income	642.9	879.9	1,026.8	1,079.5	591.7	990.2	1,179.5	1,069.6	751.4	972.9	1,111.0	1,016.5	946.7	1,146.8	1,223.7	1,109.9	1,258.5	2,639.7	1,847.2	3,347.2	1,112.7	1,167.0	1,053.1	656.4	700.1	675.7	738.5	315.6	480.0	718.1	626.9	622.2	567.2	538.8	559.9	550.3	430.5	347.0	362.8	291.6

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	12.9	12.2	19.3	3.6	8.7	10.5	13.8	14.8	16.1	18.3	17.8	18.9	18.0	17.4	15.3	13.1	13.6	14.1
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	188.3	163.8	736.5	439.2	313.3	(32.1)	313.5	558.5	(50.7)	174.7	(0.2)	66.4	(88.7)	177.9	286.1	(146.7)	(197.4)
Pre-Tax Income	831.2	1,043.7	1,763.3	1,518.7	905.0	958.1	1,493.0	1,628.1	700.7	1,147.6	1,110.8	1,082.9	858.0	1,324.7	1,509.8	963.2

Tax & Net
Income Tax Expense	104.0	199.1	303.3	127.1	96.3	40.4	152.4	195.8	(21.3)	(12.0)	103.0	114.5	40.2	127.6	194.1	111.1	87.6	274.4	184.4	653.9	137.8	75.4	156.2	21.6	44.0	97.8	98.9	31.6	85.0	(144.2)	41.2	104.7	107.4	381.2	177.3	138.1	183.4	88.4	101.1	96.0
Net Income From Continuing Ops	727.2	844.6	1,460.0	1,391.6	808.7	917.7	1,340.6	1,432.3	722.0	1,159.6	1,007.8	968.4	817.8	1,197.1	1,315.7	852.1	973.5
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	727.2	844.6	1,460.0	1,391.6	808.7	917.7	1,340.6	1,432.3	722.0	1,159.6	1,007.8	968.4	817.8	1,197.1	1,315.7	852.1	973.5
Net Income Attributable To Parent	727.2	844.6	1,460.0	1,391.6	808.7	917.7	1,340.6	1,432.3	722.0	1,159.6	1,007.8	968.4	817.8	1,197.1	1,315.7	852.1
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	727.2	844.6	1,460.0	1,391.6	808.7	917.7	1,340.6	1,432.3	722.0	1,159.6	1,007.8	968.4	817.8	1,197.1	1,315.7

Per Share
EPS Basic	6.99	-	14.09	13.24	7.58	-	12.40	13.25	6.70	-	9.48	9.05	7.64	-	12.31	7.90	9.12	-	15.37	29.51	10.58	-	7.98	8.19	5.69	-	6.12	1.77	4.23	-	5.50	5.12	4.44	-	3.64	3.66	2.36	-	2.53	1.88
EPS Diluted	6.75	-	13.62	12.81	7.27	-	11.54	12.41	6.27	-	8.89	8.50	7.17	-	11.66	7.47	8.61	-
Shares Basic	104.0	-	103.6	105.1	106.7	-	108.1	108.1	107.8	-	106.3	107.0	107.1	-	106.9	107.9	106.8	-
Shares Diluted	107.7	-	107.2	108.6	111.2	-	116.2	115.4	115.1	-	113.4	113.9	114.0	-	112.8	114.0	113.1	-

Supplementary Data
EBITDA	766.1	-	-	-	718.6	-	-	-	865.5	-	-	-	1,046.2	-	-	-	1,332.8	-	-	-	1,180.1	-	-	-	756.2	-	-	-	531.0	-	-	-	603.6	-	-	-	468.7	-	-	-
EBIT	642.9	879.9	1,026.8	1,079.5	591.7	990.2	1,179.5	1,069.6	751.4	972.9	1,111.0	1,016.5	946.7	1,146.8	1,223.7	1,109.9	1,258.5	2,639.7	1,847.2